Boston Scientific has agreed to acquire Penumbra in a cash-and-stock deal worth $14.5 billion. The addition of Penumbra, which makes mechanical thrombectomy products for vascular procedures, expands ...
Original Image Link
Source:www.msn.com
Original Image Link
Source:www.msn.com
Posted: 2026-01-15 05:45:00















